Whereas the HMGA2::MSRB3 and HMGA2::FHIT fusions were described in previous studies,3,9 the remaining detected fusion partners such as ARID2 or IFNG-AS1 are novel in this tumor type. This evidence concerns the gene MSRB3 and neoplasm.